I am holding Biomarin, and hope to reenter GILD today. We shall see.
Both look like very good deals, but...."the best laid plans".... ;-)
Well...I never thought GILD would be selling @ 9 PE, either. Crazy market. No reason, obviously, to "buy now" when one can take a chance and wait for a yet lower price. No ? PE apparently is not the only metric being used to value GILD.
I may start a new position if gild does indeed hit the mid to low 80's. Been trying to get back in for a long time.
AA is actually THE quality player in Al. Start averaging into a longer term play. I see AA getting to the 11 to 12 range in a year or so. Al is a metal that is now "in vogue" (i.e. autos, aircraft, structural, etc.). AA makes quality alloy, and NOT the typical Chinese crappola made from melted down beer cans.
How do you know what the odds are when you don't even know what the company's real earnings are ?
Political pressure will translate to VRX continuing to drop. NOBODY, but nobody, nows how badly VRX' books have been cooked. THat is why the company is being called into a Congressional wrist-slapping. NOT good for longs here, but not a stock to be short either. I may start a position if it drops another 6-8 dollars, which I think it could when the news of hearings hits the airwaves. We shall see.
We're only a little above ADV, so it evidently is not any "big news" driven event. This kind of day often happens, but Ariad then promptly sells off. Let's see if we can hold for a change.
Hmmmmmmmmmmmmmm......ARIA is enormously more RISKY than IBB. Do you need me to prove/verify this ? Anybody putting anything other than GAMBLING money into ARIA needs to know the REAL RISK extant in such a venture.
GLTA frustrated bagholders like me.
In spite of my negativity (my apology to all other longs here who wax philosophically positive about Iclusig), I DO have to agree with Souza98 that IF Brig gets the nod from the FDA, and for a specific cancer application, then Ariad is off to the races, and has a great future ahead of it. So, I guess what I am hypothecating: Intellectual property (owned by Ariad) would indeed be sought after by larger players (maybe even somebody like Gilead, Valeant, Abbvie...???). The recent reduction in force by Ariad tells me that they are feeling a cash squeeze, and are rationing out CAPEX dollars to conserve capital (a very wise move at this point. So, at least this is evidence that the BOD is not totally asleep at the wheel). Just all MHO.